Search

Hale, Andrew J, Mary LaSalvia, James E Kirby, Allison Kimball, and Rachel Baden. 2016. “Fatal Purpura Fulminans and Waterhouse-Friderichsen Syndrome from Fulminant Streptococcus Pneumoniae Sepsis in an Asplenic Young Adult.”. IDCases 6: 1-4.

Chiaraviglio, Lucius, Daniel A Brown, and James E Kirby. 2008. “Infection of Cultured Human Endothelial Cells by Legionella Pneumophila.”. PloS One 3 (4): e2012.

Kirby, J E, J P Vogel, H L Andrews, and R R Isberg. 1998. “Evidence for Pore-Forming Ability by Legionella Pneumophila.”. Molecular Microbiology 27 (2): 323-36.

Tcheng, Matthew, Vitor L S Cunha, Nawaz Ahmed, Xiaofan Liu, Richard W Smith, Kevin A Rea, Tariq A Akhtar, et al. 2021. “Structure-Activity Relationship of Avocadyne.”. Food & Function 12 (14): 6323-33.

Dong, Gao, Bohui Li, and George O’Doherty. 2020. “Total and Formal Syntheses of Fostriecin.”. Organic Chemistry Frontiers : An International Journal of Organic Chemistry 7 (22): 3608-15.

Brennan-Krohn, Thea, Roman Manetsch, George A O’Doherty, and James E Kirby. 2020. “New Strategies and Structural Considerations in Development of Therapeutics for Carbapenem-Resistant Enterobacteriaceae.”. Translational Research : The Journal of Laboratory and Clinical Medicine 220: 14-32.

Kirby, James E, Thea Brennan-Krohn, and Kenneth P Smith. 2020. “Reply to Humphries and Simner, "Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance," and Wojewoda et Al., ‘College of American Pathologists (CAP) Microbiology Committee Perspective: The Need for Verification Studies’.”. Journal of Clinical Microbiology 58 (4).

Kirby, James E. 2019. “Our Pathogens Are Not Standing Still and Neither Can We.”. Clinics in Laboratory Medicine 39 (3): xiii-xiv.